Q3 FY2026 · ended Sep 30, 2026 · Revenue $725.37M, +51.3% YoY · Filed Nov 5, 2026
Evolent Health, Inc. (EVH) files with the SEC under industry code 8741, Services-Management Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $725.4 million and a net loss of $23.6 million. As of Sep 30, 2026 it held $148.3 million in cash and investments and $973.0 million in total debt.
Revenue
$725.37M
+51.3% vs year-ago quarter
Net income
$-23.57M
-13.0% vs year-ago quarter
Operating cash flow
$26.38M
+66.8% vs year-ago quarter
Free cash flow
—
EPS
$-0.21
+12.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
113.11M
+1.3% vs year-ago quarter
Net cash
$-824.79M
Q3 FY2026
Operating margin
-18.5%
TTM
Company profile
- Industry
- Services-Management Services (SIC 8741)
- Listed as
- EVH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, VA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1628908
Other Services-Management Services companies
- Gartner Inc IT
- Rentokil Initial PLC /FI RTO
- Bryn Inc. MDTK
- Dreamland Ltd TDIC
- Sky Century Investment, Inc. SKYI
- Franklin Covey Co FC
- Kioni Holdings Ltd KNIH
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $725.4M | $652.5M | $496.2M | $468.7M | $479.5M |
| Operating income | -$6.2M | -$9.6M | -$10.6M | -$408.2M | $886,000 |
| Net income | -$23.6M | -$28.4M | -$26.6M | -$429.1M | -$20.9M |
| Diluted EPS | -$0.21 | -$0.25 | -$0.24 | -$3.84 | -$0.24 |
| Operating cash flow | $26.4M | -$9.3M | -$984,000 | $48.8M | $15.8M |
| Total assets | $2.0B | $2.0B | $1.9B | $1.9B | $2.5B |
| Total liabilities | $1.6B | $1.6B | $1.5B | $1.5B | $1.6B |
| Stockholders' equity | $372.9M | $383.2M | $396.4M | $415.2M | $842.2M |
| Cash and investments | $148.3M | $115.7M | $142.0M | $151.9M | $116.7M |
| Total debt | $973.0M | $970.4M | $985.4M | $989.7M | $1.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 857 Evolent Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.